首页 > 最新文献

Biomedical Journal最新文献

英文 中文
Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis. 晚期肝细胞癌肝移植:关于门静脉肿瘤血栓的争议。
IF 4.1 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-06-26 DOI: 10.1016/j.bj.2024.100757
Kun-Ming Chan, Wei-Chen Lee

Liver transplantation (LT) is considered the ideal treatment for hepatocellular carcinoma (HCC) concurrent with underlying cirrhotic liver disease. As well-known, LT for HCC based on the Milan criteria has shown satisfactory outcomes. However, numerous expanded transplantation criteria were proposed to benefit more patients for LT and showed comparable survivals as well. In addition, a modest expansion of transplantation criteria for HCC may be acceptable on the basis of the consensus within the transplantation community. Nonetheless, LT in patients with advanced HCC and portal vein tumor thrombosis (PVTT) recently has received attention and has been reported by many transplantation centers despite being contraindicated. Of those, the LT outcomes in certain HCC patients with PVTT were favorable. Additionally, the advancement of multimodality treatments and the evolution of systemic therapies have emerged as promising therapeutic options for downstaging advanced HCC prior to LT. Somehow, advanced HCC with PVTT could be downstaged to become eligible for LT through these multidisciplinary approaches. Although the available evidence of LT for HCC with PVTT is limited, it is hoped that LT may soon be more widely indicated for these patients. Nevertheless, several unknown factors associated with LT for HCC remain to be explored. Herein, this review aimed to update the developments in LT for patients with advanced HCC.

肝移植(LT)被认为是治疗并发肝硬化的肝细胞癌(HCC)的理想方法。众所周知,以米兰标准为基础的肝癌LT治疗效果令人满意。然而,为了让更多患者受益于LT治疗,许多扩大移植标准被提出,并显示出相当的存活率。此外,根据移植界的共识,适度扩大 HCC 移植标准也是可以接受的。尽管如此,晚期 HCC 和门静脉肿瘤血栓形成(PVTT)患者的 LT 近来受到了关注,尽管有禁忌症,但许多移植中心仍有相关报道。其中,某些伴有门静脉瘤栓形成的 HCC 患者的 LT 结果良好。此外,多模式疗法的发展和全身疗法的演变已成为在 LT 前对晚期 HCC 进行分期的有前途的治疗方案。通过这些多学科方法,晚期HCC伴PVTT患者可以通过降期治疗获得LT治疗资格。尽管现有证据表明LT治疗伴有PVTT的HCC的效果有限,但我们希望LT能在不久的将来更广泛地应用于这些患者。尽管如此,仍有一些与 HCC LT 相关的未知因素有待探索。本综述旨在介绍晚期 HCC 患者 LT 的最新进展。
{"title":"Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis.","authors":"Kun-Ming Chan, Wei-Chen Lee","doi":"10.1016/j.bj.2024.100757","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100757","url":null,"abstract":"<p><p>Liver transplantation (LT) is considered the ideal treatment for hepatocellular carcinoma (HCC) concurrent with underlying cirrhotic liver disease. As well-known, LT for HCC based on the Milan criteria has shown satisfactory outcomes. However, numerous expanded transplantation criteria were proposed to benefit more patients for LT and showed comparable survivals as well. In addition, a modest expansion of transplantation criteria for HCC may be acceptable on the basis of the consensus within the transplantation community. Nonetheless, LT in patients with advanced HCC and portal vein tumor thrombosis (PVTT) recently has received attention and has been reported by many transplantation centers despite being contraindicated. Of those, the LT outcomes in certain HCC patients with PVTT were favorable. Additionally, the advancement of multimodality treatments and the evolution of systemic therapies have emerged as promising therapeutic options for downstaging advanced HCC prior to LT. Somehow, advanced HCC with PVTT could be downstaged to become eligible for LT through these multidisciplinary approaches. Although the available evidence of LT for HCC with PVTT is limited, it is hoped that LT may soon be more widely indicated for these patients. Nevertheless, several unknown factors associated with LT for HCC remain to be explored. Herein, this review aimed to update the developments in LT for patients with advanced HCC.</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronobioethics: Symphony of biological clocks observed by 7-day/24-hour ambulatory blood pressure monitoring and cardiovascular health. 时间生物伦理学:通过 7 天/24 小时动态血压监测观察到的生物钟交响乐与心血管健康。
IF 4.1 3区 医学 Q1 Medicine Pub Date : 2024-06-19 DOI: 10.1016/j.bj.2024.100753
Kuniaki Otsuka, Larry A Beaty, Madoka Sato, Kazunobu Shitakura, Tomoko Kikuchi, Kiyotaka Okajima, Shigehiko Terada, Germaine Cornelissen

Background: The high prevalence of desynchronized biological rhythms is becoming a primary public health concern. We assess complex and diverse inter-modulations among multi-frequency rhythms present in blood pressure (BP) and heart rate (HR).

Subjects: and Methods: We performed 7-day/24-hour Ambulatory BP Monitoring in 220 (133 women) residents (23 to 74 years) of a rural Japanese town in Kochi Prefecture under everyday life conditions.

Results: A symphony of biological clocks contributes to the preservation of a synchronized circadian system. (1) Citizens with an average 12.02-h period had fewer vascular variability disorders than those with shorter (11.37-h) or longer (12.88-h) periods (P<0.05), suggesting that the circasemidian rhythm is potentially important for human health. (2) An appropriate BP-HR coupling promoted healthier circadian profiles than a phase-advanced BP: lower 7-day nighttime SBP (106.8 vs. 112.9 mmHg, P=0.0469), deeper nocturnal SBP dip (20.5% vs. 16.8%, P=0.0101), and less frequent incidence of masked non-dipping (0.53 vs. 0.86, P=0.0378), identifying the night as an important time window.

Conclusion: Adaptation to irregular schedules in everyday life occurs unconsciously at night, probably initiated from the brain default mode network, in coordination with the biological clock system, including a reinforced about 12-hour clock, as "a biological clock-guided core integration system".

背景:不同步生物节律的高发生率正成为公共健康的首要问题。我们评估了血压(BP)和心率(HR)中多频节律之间复杂多样的相互调制:我们对高知县一个日本农村小镇的 220 名居民(133 名女性)(23 至 74 岁)进行了日常生活条件下的 7 天/24 小时动态血压监测:生物钟的交响乐有助于保持昼夜节律系统的同步。(1) 与昼夜节律较短(11.37 小时)或较长(12.88 小时)的人相比,平均昼夜节律为 12.02 小时的人患血管变异性疾病的几率较低(结论:昼夜节律不规律的生活适应性有助于保持昼夜节律系统的同步:对日常生活中不规则时间安排的适应是在夜间无意识地发生的,可能是由大脑默认模式网络与生物钟系统(包括强化的约 12 小时时钟)协调启动的,是 "生物钟引导的核心整合系统"。
{"title":"Chronobioethics: Symphony of biological clocks observed by 7-day/24-hour ambulatory blood pressure monitoring and cardiovascular health.","authors":"Kuniaki Otsuka, Larry A Beaty, Madoka Sato, Kazunobu Shitakura, Tomoko Kikuchi, Kiyotaka Okajima, Shigehiko Terada, Germaine Cornelissen","doi":"10.1016/j.bj.2024.100753","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100753","url":null,"abstract":"<p><strong>Background: </strong>The high prevalence of desynchronized biological rhythms is becoming a primary public health concern. We assess complex and diverse inter-modulations among multi-frequency rhythms present in blood pressure (BP) and heart rate (HR).</p><p><strong>Subjects: </strong>and Methods: We performed 7-day/24-hour Ambulatory BP Monitoring in 220 (133 women) residents (23 to 74 years) of a rural Japanese town in Kochi Prefecture under everyday life conditions.</p><p><strong>Results: </strong>A symphony of biological clocks contributes to the preservation of a synchronized circadian system. (1) Citizens with an average 12.02-h period had fewer vascular variability disorders than those with shorter (11.37-h) or longer (12.88-h) periods (P<0.05), suggesting that the circasemidian rhythm is potentially important for human health. (2) An appropriate BP-HR coupling promoted healthier circadian profiles than a phase-advanced BP: lower 7-day nighttime SBP (106.8 vs. 112.9 mmHg, P=0.0469), deeper nocturnal SBP dip (20.5% vs. 16.8%, P=0.0101), and less frequent incidence of masked non-dipping (0.53 vs. 0.86, P=0.0378), identifying the night as an important time window.</p><p><strong>Conclusion: </strong>Adaptation to irregular schedules in everyday life occurs unconsciously at night, probably initiated from the brain default mode network, in coordination with the biological clock system, including a reinforced about 12-hour clock, as \"a biological clock-guided core integration system\".</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141436624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-throughput Proteomics-Guided Biomarker Discovery of Hepatocellular Carcinoma. 高通量蛋白质组学引导下的肝细胞癌生物标志物发现。
IF 4.1 3区 医学 Q1 Medicine Pub Date : 2024-06-18 DOI: 10.1016/j.bj.2024.100752
Dongyoon Shin, Yeongshin Kim, Junho Park, Youngsoo Kim

Liver cancer stands as the fifth leading cause of cancer-related deaths globally. Hepatocellular carcinoma (HCC) comprises approximately 85%-90% of all primary liver malignancies. However, only 20-30% of HCC patients qualify for curative therapy, primarily due to the absence of reliable tools for early detection and prognosis of HCC. This underscores the critical need for molecular biomarkers for HCC management. Since proteins reflect disease status directly, proteomics has been utilized in biomarker developments for HCC. In particular, proteomics coupled with liquid chromatography-mass spectrometer (LC-MS) methods facilitate the process of discovering biomarker candidates for diagnosis, prognosis, and therapeutic strategies. In this work, we investigated LC-MS-based proteomics methods through recent reference reviews, with a particular focus on sample preparation and LC-MS methods appropriate for the discovery of HCC biomarkers and their clinical applications. We classified proteomics studies of HCC according to sample types, and we examined the coverage of protein biomarker candidates based on LC-MS methods in relation to study scales and goals. Comprehensively, we proposed protein biomarker candidates categorized by sample types and biomarker types for appropriate clinical use. In this review, we summarized recent LC-MS-based proteomics studies on HCC and proposed potential protein biomarkers. Our findings are expected to expand the understanding of HCC pathogenesis and enhance the efficiency of HCC diagnosis and prognosis, thereby contributing to improved patient outcomes.

肝癌是全球癌症相关死亡的第五大主要原因。肝细胞癌(HCC)约占所有原发性肝脏恶性肿瘤的85%-90%。然而,只有 20%-30% 的 HCC 患者有资格接受根治性治疗,这主要是由于缺乏可靠的 HCC 早期检测和预后工具。这凸显了HCC治疗对分子生物标志物的迫切需要。由于蛋白质能直接反映疾病状态,因此蛋白质组学已被用于 HCC 生物标志物的开发。特别是,蛋白质组学与液相色谱-质谱联用(LC-MS)方法有助于发现用于诊断、预后和治疗策略的候选生物标记物。在这项工作中,我们通过最近的参考文献综述研究了基于液相色谱-质谱的蛋白质组学方法,尤其关注适合发现 HCC 生物标志物及其临床应用的样品制备和液相色谱-质谱方法。我们根据样本类型对 HCC 蛋白质组学研究进行了分类,并结合研究规模和目标考察了基于 LC-MS 方法的候选蛋白质生物标志物的覆盖范围。综上所述,我们提出了按样本类型和生物标记物类型分类的候选蛋白质生物标记物,以供临床使用。在这篇综述中,我们总结了近期基于 LC-MS 的 HCC 蛋白质组学研究,并提出了潜在的蛋白质生物标记物。我们的研究结果有望拓展人们对 HCC 发病机制的认识,提高 HCC 诊断和预后的效率,从而改善患者的预后。
{"title":"High-throughput Proteomics-Guided Biomarker Discovery of Hepatocellular Carcinoma.","authors":"Dongyoon Shin, Yeongshin Kim, Junho Park, Youngsoo Kim","doi":"10.1016/j.bj.2024.100752","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100752","url":null,"abstract":"<p><p>Liver cancer stands as the fifth leading cause of cancer-related deaths globally. Hepatocellular carcinoma (HCC) comprises approximately 85%-90% of all primary liver malignancies. However, only 20-30% of HCC patients qualify for curative therapy, primarily due to the absence of reliable tools for early detection and prognosis of HCC. This underscores the critical need for molecular biomarkers for HCC management. Since proteins reflect disease status directly, proteomics has been utilized in biomarker developments for HCC. In particular, proteomics coupled with liquid chromatography-mass spectrometer (LC-MS) methods facilitate the process of discovering biomarker candidates for diagnosis, prognosis, and therapeutic strategies. In this work, we investigated LC-MS-based proteomics methods through recent reference reviews, with a particular focus on sample preparation and LC-MS methods appropriate for the discovery of HCC biomarkers and their clinical applications. We classified proteomics studies of HCC according to sample types, and we examined the coverage of protein biomarker candidates based on LC-MS methods in relation to study scales and goals. Comprehensively, we proposed protein biomarker candidates categorized by sample types and biomarker types for appropriate clinical use. In this review, we summarized recent LC-MS-based proteomics studies on HCC and proposed potential protein biomarkers. Our findings are expected to expand the understanding of HCC pathogenesis and enhance the efficiency of HCC diagnosis and prognosis, thereby contributing to improved patient outcomes.</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice. Hirsutella sinensis 多糖和 Parabacteroides goldsteinii 可减轻咪喹莫特治疗小鼠狼疮的严重程度。
IF 4.1 3区 医学 Q1 Medicine Pub Date : 2024-06-18 DOI: 10.1016/j.bj.2024.100754
Shih-Hsin Chang, Yun-Fei Ko, Jian-Ching Liau, Cheng-Yeu Wu, Tsong-Long Hwang, David M Ojcius, John D Young, Jan Martel

Background: The incidence of autoimmune diseases is increasing in developed countries, possibly due to the modern Western diet and lifestyle. We showed earlier that polysaccharides derived from the medicinal fungus Hirsutella sinensis produced anti-inflammatory, anti-diabetic and anti-obesity effects by modulating the gut microbiota and increasing the abundance of the commensal Parabacteroides goldsteinii in mice fed with a high-fat diet.

Methods: We examined the effects of the prebiotics, H. sinensis polysaccharides, and probiotic, P. goldsteinii, in a mouse model of imiquimod-induced systemic lupus erythematosus.

Results: The fungal polysaccharides and P. goldsteinii reduced markers of lupus severity, including the increase of spleen weight, proteinuria, and serum levels of anti-DNA auto-antibodies and signal transducer and activator of transcription 4 (STAT4). Moreover, the polysaccharides and P. goldsteinii improved markers of kidney and liver functions such as creatinine, blood urea nitrogen, glomerulus damage and fibrosis, and serum liver enzymes. However, the prebiotics and probiotics did not influence gut microbiota composition, colonic histology, or expression of tight junction proteins in colon tissues.

Conclusions: Our results indicate that H. sinensis polysaccharides and the probiotic P. goldsteinii can reduce lupus markers in imiquimod-treated mice. These prebiotics and probiotics may therefore be added to other interventions conducive of a healthy lifestyle in order to counter autoimmune diseases.

背景:在发达国家,自身免疫性疾病的发病率正在上升,这可能与现代西方饮食和生活方式有关。我们早些时候研究发现,从药用真菌中华大孔菌中提取的多糖通过调节肠道微生物群和增加高脂饮食喂养的小鼠体内共生菌 Parabacteroides goldsteinii 的丰度,产生抗炎、抗糖尿病和抗肥胖的作用:我们在咪喹莫特诱导的系统性红斑狼疮小鼠模型中研究了益生菌中华蘑菇多糖和益生菌金丝桃的作用:结果:真菌多糖和金孢子菌降低了狼疮严重程度的指标,包括脾脏重量增加、蛋白尿、血清中抗 DNA 自身抗体和转录信号转导子和激活子 4(STAT4)的水平。此外,金丝桃多糖和金丝桃还能改善肝肾功能指标,如肌酐、血尿素氮、肾小球损伤和纤维化以及血清肝酶。然而,益生元和益生菌并不影响肠道微生物群的组成、结肠组织学或结肠组织中紧密连接蛋白的表达:我们的研究结果表明,中华猪多糖和益生菌金丝桃可以减少咪喹莫特治疗小鼠的狼疮指标。因此,这些益生元和益生菌可与其他有利于健康生活方式的干预措施相结合,以对抗自身免疫性疾病。
{"title":"Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice.","authors":"Shih-Hsin Chang, Yun-Fei Ko, Jian-Ching Liau, Cheng-Yeu Wu, Tsong-Long Hwang, David M Ojcius, John D Young, Jan Martel","doi":"10.1016/j.bj.2024.100754","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100754","url":null,"abstract":"<p><strong>Background: </strong>The incidence of autoimmune diseases is increasing in developed countries, possibly due to the modern Western diet and lifestyle. We showed earlier that polysaccharides derived from the medicinal fungus Hirsutella sinensis produced anti-inflammatory, anti-diabetic and anti-obesity effects by modulating the gut microbiota and increasing the abundance of the commensal Parabacteroides goldsteinii in mice fed with a high-fat diet.</p><p><strong>Methods: </strong>We examined the effects of the prebiotics, H. sinensis polysaccharides, and probiotic, P. goldsteinii, in a mouse model of imiquimod-induced systemic lupus erythematosus.</p><p><strong>Results: </strong>The fungal polysaccharides and P. goldsteinii reduced markers of lupus severity, including the increase of spleen weight, proteinuria, and serum levels of anti-DNA auto-antibodies and signal transducer and activator of transcription 4 (STAT4). Moreover, the polysaccharides and P. goldsteinii improved markers of kidney and liver functions such as creatinine, blood urea nitrogen, glomerulus damage and fibrosis, and serum liver enzymes. However, the prebiotics and probiotics did not influence gut microbiota composition, colonic histology, or expression of tight junction proteins in colon tissues.</p><p><strong>Conclusions: </strong>Our results indicate that H. sinensis polysaccharides and the probiotic P. goldsteinii can reduce lupus markers in imiquimod-treated mice. These prebiotics and probiotics may therefore be added to other interventions conducive of a healthy lifestyle in order to counter autoimmune diseases.</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel artificial tricalcium phosphate and magnesium composite graft facilitates angiogenesis in bone healing. 新型人工磷酸三钙和镁复合移植物可促进骨愈合过程中的血管生成。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-06-03 DOI: 10.1016/j.bj.2024.100750
Yuan-Hsin Tsai, Chun-Chieh Tseng, Yun-Chan Lin, Howida M Nail, Kuan-Yu Chiu, Yen-Hao Chang, Ming-Wei Chang, Feng-Huei Lin, Hui-Min David Wang

Background: Bone grafting is the standard treatment for critical bone defects, but autologous grafts have limitations like donor site morbidity and limited availability, while commercial artificial grafts may have poor integration with surrounding bone tissue, leading to delayed healing. Magnesium deficiency negatively impacts angiogenesis and bone repair. Therefore, incorporating magnesium into a synthetic biomaterial could provide an excellent bone substitute. This study aims to evaluate the morphological, mechanical, and biological properties of a calcium phosphate cement (CPC) sponge composed of tetracalcium phosphate (TTCP) and monocalcium phosphate monohydrate (MCPM), which could serve as an excellent bone substitute by incorporating magnesium.

Methods: This study aims to develop biomedical materials composed mainly of TTCP and MCPM powder, magnesium powder, and collagen. The materials were prepared using a wet-stirred mill and freeze-dryer methods. The particle size, composition, and microstructure of the materials were investigated. Finally, the biological properties of these materials, including 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay for biocompatibility, effects on bone cell differentiation by alkaline phosphatase (ALP) activity assay and tartrate-resistant acid phosphatase (TRAP) activity assay, and endothelial cell tube formation assay for angiogenesis, were evaluated as well.

Results: The data showed that the sub-micron CPC powder, composed of TTCP/MCPM in a 3.5:1 ratio, had a setting time shorter than 15 minutes and a compressive strength of 4.39±0.96 MPa. This reveals that the sub-micron CPC powder had an adequate setting time and mechanical strength. We found that the sub-micron CPC sponge containing magnesium had better biocompatibility, including increased proliferation and osteogenic induction effects without cytotoxicity. The CPC sponge containing magnesium also promoted angiogenesis.

Conclusion: In summary, we introduced a novel CPC sponge, which had a similar property to human bone promoted the biological functions of bone cells, and could serve as a promising material used in bone regeneration for critical bone defects.

背景:骨移植是治疗严重骨缺损的标准方法,但自体移植存在供体部位发病率高、可用性有限等局限性,而商用人工移植可能与周围骨组织结合不佳,导致愈合延迟。镁的缺乏会对血管生成和骨修复产生负面影响。因此,在合成生物材料中加入镁元素可以提供极佳的骨替代品。本研究旨在评估由磷酸四钙(TTCP)和一水磷酸一钙(MCPM)组成的磷酸钙骨水泥(CPC)海绵的形态、机械和生物特性:本研究旨在开发主要由 TTCP 和 MCPM 粉末、镁粉和胶原蛋白组成的生物医学材料。材料采用湿法搅拌研磨和冷冻干燥法制备。研究了材料的粒度、成分和微观结构。最后,还评估了这些材料的生物特性,包括 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑(MTT)生物相容性测定、碱性磷酸酶(ALP)活性测定和耐酒石酸磷酸酶(TRAP)活性测定对骨细胞分化的影响,以及血管生成的内皮细胞管形成测定:数据显示,由 TTCP/MCPM 以 3.5:1 的比例组成的亚微米 CPC 粉末的凝固时间短于 15 分钟,抗压强度为 4.39±0.96 兆帕。这表明亚微米 CPC 粉末具有足够的凝固时间和机械强度。我们发现,含镁的亚微米 CPC 海绵具有更好的生物相容性,包括增殖和成骨诱导效应,且无细胞毒性。含镁的 CPC 海绵还能促进血管生成:综上所述,我们介绍了一种新型 CPC 海绵,它具有与人类骨骼相似的特性,能促进骨细胞的生物功能,可作为一种有前途的材料用于关键骨缺损的骨再生。
{"title":"Novel artificial tricalcium phosphate and magnesium composite graft facilitates angiogenesis in bone healing.","authors":"Yuan-Hsin Tsai, Chun-Chieh Tseng, Yun-Chan Lin, Howida M Nail, Kuan-Yu Chiu, Yen-Hao Chang, Ming-Wei Chang, Feng-Huei Lin, Hui-Min David Wang","doi":"10.1016/j.bj.2024.100750","DOIUrl":"https://doi.org/10.1016/j.bj.2024.100750","url":null,"abstract":"<p><strong>Background: </strong>Bone grafting is the standard treatment for critical bone defects, but autologous grafts have limitations like donor site morbidity and limited availability, while commercial artificial grafts may have poor integration with surrounding bone tissue, leading to delayed healing. Magnesium deficiency negatively impacts angiogenesis and bone repair. Therefore, incorporating magnesium into a synthetic biomaterial could provide an excellent bone substitute. This study aims to evaluate the morphological, mechanical, and biological properties of a calcium phosphate cement (CPC) sponge composed of tetracalcium phosphate (TTCP) and monocalcium phosphate monohydrate (MCPM), which could serve as an excellent bone substitute by incorporating magnesium.</p><p><strong>Methods: </strong>This study aims to develop biomedical materials composed mainly of TTCP and MCPM powder, magnesium powder, and collagen. The materials were prepared using a wet-stirred mill and freeze-dryer methods. The particle size, composition, and microstructure of the materials were investigated. Finally, the biological properties of these materials, including 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay for biocompatibility, effects on bone cell differentiation by alkaline phosphatase (ALP) activity assay and tartrate-resistant acid phosphatase (TRAP) activity assay, and endothelial cell tube formation assay for angiogenesis, were evaluated as well.</p><p><strong>Results: </strong>The data showed that the sub-micron CPC powder, composed of TTCP/MCPM in a 3.5:1 ratio, had a setting time shorter than 15 minutes and a compressive strength of 4.39±0.96 MPa. This reveals that the sub-micron CPC powder had an adequate setting time and mechanical strength. We found that the sub-micron CPC sponge containing magnesium had better biocompatibility, including increased proliferation and osteogenic induction effects without cytotoxicity. The CPC sponge containing magnesium also promoted angiogenesis.</p><p><strong>Conclusion: </strong>In summary, we introduced a novel CPC sponge, which had a similar property to human bone promoted the biological functions of bone cells, and could serve as a promising material used in bone regeneration for critical bone defects.</p>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141260452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression 长非编码 RNA TUG1 通过增强 ZBTB7C 的表达促进骨肉瘤的恶性发展
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100651
Xueying An , Wenshu Wu , Pu Wang , Abdurahman Mahmut , Junxia Guo , Jian Dong , Wang Gong , Bin Liu , Lin Yang , Yuze Ma , Xingquan Xu , Jianmei Chen , Wangsen Cao , Qing Jiang

Background

Dysregulation of long non-coding RNAs (lncRNAs) is an important component of tumorigenesis. Aberrant expression of lncRNA taurine upregulated gene 1 (lncTUG1) has been reported in various tumors; however, its precise role and key targets critically involved in osteosarcoma (OS) progression remain unclear.

Methods

The expression profiles of lncRNAs and their regulated miRNAs related to OS progression were assessed by bioinformatics analysis and confirmed by qRT-PCR of OS cells. The miRNA targets were identified by transcriptome sequencing and verified by luciferase reporter and RNA pull-down assays. Several in vivo and in vitro approaches, including CCK8 assay, western blot, qRT-PCR, lentiviral transduction and OS cell xenograft mouse model were established to validate the effects of lncTUG1 regulation of miRNA and the downstream target genes on OS cell growth, apoptosis and progression.

Results

We found that lncTUG1 and miR-26a-5p were inversely up or down-regulated in OS cells, and siRNA-mediated lncTUG1 knockdown reversed the miR-26a-5p down-regulation and suppressed proliferation and enhanced apoptosis of OS cells. Further, we identified that an oncoprotein ZBTB7C was also upregulated in OS cells that were subjected to lncTUG1/miR-26a-5p regulation. More importantly, ZBTB7C knockdown reduced the ZBTB7C upregulation and ZBTB7C overexpression diminished the anti-OS effects of lncTUG1 knockdown in the OS xenograft model.

Conclusions

Our data suggest that lncTUG1 acts as a miR-26a-5p sponge and promotes OS progression via up-regulating ZBTB7C, and targeting lncTUG1 might be an effective strategy to treat OS.

背景长非编码 RNA(lncRNA)的失调是肿瘤发生的一个重要组成部分。方法通过生物信息学分析评估了与骨肉瘤进展相关的lncRNA及其调控的miRNA的表达谱,并通过骨肉瘤细胞的qRT-PCR进行了确认。通过转录组测序确定了miRNA的靶标,并通过荧光素酶报告和RNA下拉实验进行了验证。通过CCK8检测、Western印迹、qRT-PCR、慢病毒转导和OS细胞异种移植小鼠模型等多种体内和体外方法,验证了lncTUG1调控miRNA及其下游靶基因对OS细胞生长、凋亡和进展的影响。结果 我们发现,lncTUG1和miR-26a-5p在OS细胞中呈反向上调或下调,siRNA介导的lncTUG1敲除逆转了miR-26a-5p的下调,抑制了OS细胞的增殖并增强了其凋亡。此外,我们还发现,在受到lncTUG1/miR-26a-5p调控的OS细胞中,一种肿瘤蛋白ZBTB7C也出现了上调。结论我们的数据表明,lncTUG1作为miR-26a-5p海绵,通过上调ZBTB7C促进OS进展,靶向lncTUG1可能是治疗OS的有效策略。
{"title":"Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression","authors":"Xueying An ,&nbsp;Wenshu Wu ,&nbsp;Pu Wang ,&nbsp;Abdurahman Mahmut ,&nbsp;Junxia Guo ,&nbsp;Jian Dong ,&nbsp;Wang Gong ,&nbsp;Bin Liu ,&nbsp;Lin Yang ,&nbsp;Yuze Ma ,&nbsp;Xingquan Xu ,&nbsp;Jianmei Chen ,&nbsp;Wangsen Cao ,&nbsp;Qing Jiang","doi":"10.1016/j.bj.2023.100651","DOIUrl":"10.1016/j.bj.2023.100651","url":null,"abstract":"<div><h3>Background</h3><p>Dysregulation of long non-coding RNAs (lncRNAs) is an important component of tumorigenesis. Aberrant expression of lncRNA taurine upregulated gene 1 (lncTUG1) has been reported in various tumors; however, its precise role and key targets critically involved in osteosarcoma (OS) progression remain unclear.</p></div><div><h3>Methods</h3><p>The expression profiles of lncRNAs and their regulated miRNAs related to OS progression were assessed by bioinformatics analysis and confirmed by qRT-PCR of OS cells. The miRNA targets were identified by transcriptome sequencing and verified by luciferase reporter and RNA pull-down assays. Several <em>in vivo</em> and <em>in vitro</em> approaches, including CCK8 assay, western blot, qRT-PCR, lentiviral transduction and OS cell xenograft mouse model were established to validate the effects of lncTUG1 regulation of miRNA and the downstream target genes on OS cell growth, apoptosis and progression.</p></div><div><h3>Results</h3><p>We found that lncTUG1 and miR-26a-5p were inversely up or down-regulated in OS cells, and siRNA-mediated lncTUG1 knockdown reversed the miR-26a-5p down-regulation and suppressed proliferation and enhanced apoptosis of OS cells. Further, we identified that an oncoprotein ZBTB7C was also upregulated in OS cells that were subjected to lncTUG1/miR-26a-5p regulation. More importantly, ZBTB7C knockdown reduced the ZBTB7C upregulation and ZBTB7C overexpression diminished the anti-OS effects of lncTUG1 knockdown in the OS xenograft model.</p></div><div><h3>Conclusions</h3><p>Our data suggest that lncTUG1 acts as a miR-26a-5p sponge and promotes OS progression <em>via</em> up-regulating ZBTB7C, and targeting lncTUG1 might be an effective strategy to treat OS.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000884/pdfft?md5=3064c0fef20489eefc4debd0e794f500&pid=1-s2.0-S2319417023000884-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9974615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes 获得性免疫缺陷综合症与 SARS-CoV-2 N 基因型的相关性。
IF 4.1 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100650

Background

Epigenetics and clinical observations referring to Betacoronavirus lead to the conjecture that Sarbecovirus may have the ability to infect lymphocytes using a different way than the spike protein. In addition to inducing the death of lymphocytes, thus drastically reducing their population and causing a serious immune deficiency, allows it to remain hidden for long periods of latency using them as a viral reservoir in what is named Long-Covid Disease. Exploring possibilities, the hypothesis is focused on that N protein may be the key of infecting lymphocytes.

Method

The present article exhibits a computational assay for the latest complete sequences reported to GISAID, correlating N genotypes with an enhancement in the affinity of the complex that causes immune deficiency in order to determine a good docking with the N protein and some receptors in lymphocytes.

Results

A novel high-interaction coupling of N-RBD and CD147 is presented as the main way of infecting lymphocytes, allowing to define those genotypes involved in their affinity enhancement.

Conclusion

The hypothesis is consistent with the mutagenic deriving observed on the in-silico assay, which reveals that genotypes N/120 and N/152 are determinant to reduce the Immune Response of the host infecting lymphocytes, allowing the virus persists indefinitely and causing an Acquire Immune Deficiency Syndrome.

背景:根据表观遗传学和对 Betacoronavirus 的临床观察,我们推测 Sarbecovirus 可能有能力以不同于尖峰蛋白的方式感染淋巴细胞。除了诱导淋巴细胞死亡,从而使淋巴细胞数量急剧下降并导致严重的免疫缺陷外,它还能利用淋巴细胞作为病毒库长期潜伏,这就是所谓的 "长病毒病"。在探索各种可能性的过程中,假设的重点是 N 蛋白可能是感染淋巴细胞的关键:本文展示了对 GISAID 报告的最新完整序列的计算分析,将 N 基因型与导致免疫缺陷的复合物亲和力增强联系起来,以确定 N 蛋白与淋巴细胞中某些受体的良好对接:结果:N-RBD和CD147的新型高相互作用耦合被认为是感染淋巴细胞的主要方式,从而确定了参与亲和力增强的基因型:结论:该假说与在微观分析中观察到的诱变衍生一致,揭示了基因型 N/120 和 N/152 是降低宿主感染淋巴细胞免疫反应的决定性因素,从而使病毒无限期存在并导致获得性免疫缺陷综合症。
{"title":"Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes","authors":"","doi":"10.1016/j.bj.2023.100650","DOIUrl":"10.1016/j.bj.2023.100650","url":null,"abstract":"<div><h3>Background</h3><p>Epigenetics and clinical observations referring to Betacoronavirus lead to the conjecture that Sarbecovirus may have the ability to infect lymphocytes using a different way than the spike protein. In addition to inducing the death of lymphocytes, thus drastically reducing their population and causing a serious immune deficiency, allows it to remain hidden for long periods of latency using them as a viral reservoir in what is named Long-Covid Disease. Exploring possibilities, the hypothesis is focused on that N protein may be the key of infecting lymphocytes.</p></div><div><h3>Method</h3><p>The present article exhibits a computational assay for the latest complete sequences reported to GISAID, correlating N genotypes with an enhancement in the affinity of the complex that causes immune deficiency in order to determine a good docking with the N protein and some receptors in lymphocytes.</p></div><div><h3>Results</h3><p>A novel high-interaction coupling of N-RBD and CD147 is presented as the main way of infecting lymphocytes, allowing to define those genotypes involved in their affinity enhancement.</p></div><div><h3>Conclusion</h3><p>The hypothesis is consistent with the mutagenic deriving observed on the in-silico assay, which reveals that genotypes N/120 and N/152 are determinant to reduce the Immune Response of the host infecting lymphocytes, allowing the virus persists indefinitely and causing an Acquire Immune Deficiency Syndrome.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000872/pdfft?md5=1edaaac170d38d8c21d14f03478af8b3&pid=1-s2.0-S2319417023000872-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10030002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut mycobiome in metabolic diseases: Mechanisms and clinical implication 代谢性疾病中的肠道霉菌生物群:机制和临床意义。
IF 4.1 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100625

Obesity, type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are three common metabolic diseases with high prevalence worldwide. Emerging evidence suggests that gut dysbiosis may influence the development of metabolic diseases, in which gut fungal microbiome (mycobiome) is actively involved. In this review, we summarize the studies exploring the composition changes of gut mycobiome in metabolic diseases and mechanisms by which fungi affect the development of metabolic diseases. The current mycobiome-based therapies, including probiotic fungi, fungal products, anti-fungal agents and fecal microbiota transplantation (FMT), and their implication in treating metabolic diseases are discussed. We highlight the unique role of gut mycobiome in metabolic diseases, providing perspectives for future research on gut mycobiome in metabolic diseases.

肥胖症、2 型糖尿病(T2DM)和非酒精性脂肪肝(NAFLD)是全球发病率较高的三种常见代谢性疾病。新的证据表明,肠道菌群失调可能会影响代谢性疾病的发生,而肠道真菌微生物组(mycobiome)则积极参与其中。在这篇综述中,我们总结了探索代谢性疾病中肠道真菌生物群组成变化的研究,以及真菌影响代谢性疾病发生的机制。我们还讨论了目前基于真菌生物群的疗法,包括益生菌、真菌产品、抗真菌药物和粪便微生物群移植(FMT),以及它们在治疗代谢性疾病中的作用。我们强调了肠道真菌生物群在代谢性疾病中的独特作用,为今后研究代谢性疾病中的肠道真菌生物群提供了前景。
{"title":"Gut mycobiome in metabolic diseases: Mechanisms and clinical implication","authors":"","doi":"10.1016/j.bj.2023.100625","DOIUrl":"10.1016/j.bj.2023.100625","url":null,"abstract":"<div><p>Obesity, type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are three common metabolic diseases with high prevalence worldwide. Emerging evidence suggests that gut dysbiosis may influence the development of metabolic diseases, in which gut fungal microbiome (mycobiome) is actively involved. In this review, we summarize the studies exploring the composition changes of gut mycobiome in metabolic diseases and mechanisms by which fungi affect the development of metabolic diseases. The current mycobiome-based therapies, including probiotic fungi, fungal products, anti-fungal agents and fecal microbiota transplantation (FMT), and their implication in treating metabolic diseases are discussed. We highlight the unique role of gut mycobiome in metabolic diseases, providing perspectives for future research on gut mycobiome in metabolic diseases.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000628/pdfft?md5=afebb46db7828c38f6f0185daf91db90&pid=1-s2.0-S2319417023000628-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10045400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing transvenous coiling and transarterial embolization with Onyx/NBCA for cavernous sinus dural arteriovenous fistulas: A retrospective study in a single center 海绵窦硬脑膜动静脉瘘的经静脉套扎术和经动脉栓塞术与 Onyx/NBCA 的比较:单个中心的回顾性研究
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100657
Yi-Ming Wu , Chuan-Min Lin , Sachin Giri , Yao-liang Chen , Chien-Hung Chang , Ho-Fai Wong

Background

Endovascular management is the gold standard for cavernous sinus dural arteriovenous fistulas (CS-dAVFs) in patients with signs of ophthalmoplegia, visual defects, or intolerable clinical symptoms. Although the efficacy of embolization has been confirmed, complications during post-endovascular management have not been compared in a more extensive CS-dAVFs case series. Therefore, we compared the effectiveness and peri-procedural complications of transvenous coiling with those of transarterial embolization (TAE) using liquid embolic agents.

Methods

We reviewed 71 patients with CS-dAVFs in one medical center from 2005/7 to 2016/7. We performed seventy-seven procedures on 71 patients, including six recurrent cases. We compared the efficacy and peri-procedural complications of transvenous coiling and TAE.

Results

The complete occlusion rate for transvenous coiling was 79.2%, and that for TAE was 75.0%. Findings revealed (1) similar ophthalmoplegia complication rates (p = 0.744); (2) more frequent and permanent CN5 or CN7 neuropathy with liquid embolic agent use (p = 0.031 and 0.028, respectively); and (3) a higher risk of infarction or ICH (p = 0.002 and 0.028, respectively) in response to aggressive TAE.

Conclusion

Transvenous cavernous sinus coiling resulted in a similar occlusion rate and lower complication risk than transarterial Onyx/n-butyl cyanoacrylate (NBCA). We can access via an occluded inferior petrosal sinus (even contralateral), and direct transorbital puncture was a safe alternative. TAE with Onyx/NBCA was helpful in cases of oligo-feeders, but multidisciplinary treatment and multi-session TAE were usually needed for patients with multiple feeders and complex fistulas.

背景血管内治疗是海绵窦硬脑膜动静脉瘘(CS-dAVFs)的金标准,适用于有眼球震颤、视力缺陷或无法忍受的临床症状的患者。虽然栓塞治疗的疗效已得到证实,但在更广泛的 CS-dAVFs 病例系列中,尚未对血管内治疗后的并发症进行比较。因此,我们比较了经静脉套扎术与使用液体栓塞剂的经动脉栓塞术(TAE)的疗效和术中并发症。我们为 71 名患者实施了 77 例手术,其中包括 6 例复发病例。结果经静脉套扎术的完全闭塞率为 79.2%,TAE 为 75.0%。研究结果显示:(1) 眼球震颤并发症发生率相似(p = 0.744);(2) 使用液体栓塞剂时,CN5 或 CN7 神经病变更频繁且更永久(p = 0.031 和 0.028,分别为 0.031 和 0.028);(3) 梗死或 ICH 风险更高(p = 0.结论与经动脉Onyx/氰基丙烯酸丁酯(NBCA)相比,经静脉海绵窦旋切术的闭塞率相似,并发症风险更低。)我们可以从闭塞的下鼻底窦(甚至对侧)进入,直接经眶穿刺是一种安全的替代方法。使用 Onyx/NBCA 进行 TAE 对少馈源病例很有帮助,但对于多馈源和复杂瘘管患者,通常需要多学科治疗和多次 TAE。
{"title":"Comparing transvenous coiling and transarterial embolization with Onyx/NBCA for cavernous sinus dural arteriovenous fistulas: A retrospective study in a single center","authors":"Yi-Ming Wu ,&nbsp;Chuan-Min Lin ,&nbsp;Sachin Giri ,&nbsp;Yao-liang Chen ,&nbsp;Chien-Hung Chang ,&nbsp;Ho-Fai Wong","doi":"10.1016/j.bj.2023.100657","DOIUrl":"10.1016/j.bj.2023.100657","url":null,"abstract":"<div><h3>Background</h3><p>Endovascular management is the gold standard for cavernous sinus dural arteriovenous fistulas (CS-dAVFs) in patients with signs of ophthalmoplegia, visual defects, or intolerable clinical symptoms. Although the efficacy of embolization has been confirmed, complications during post-endovascular management have not been compared in a more extensive CS-dAVFs case series. Therefore, we compared the effectiveness and peri-procedural complications of transvenous coiling with those of transarterial embolization (TAE) using liquid embolic agents.</p></div><div><h3>Methods</h3><p>We reviewed 71 patients with CS-dAVFs in one medical center from 2005/7 to 2016/7. We performed seventy-seven procedures on 71 patients, including six recurrent cases. We compared the efficacy and peri-procedural complications of transvenous coiling and TAE.</p></div><div><h3>Results</h3><p>The complete occlusion rate for transvenous coiling was 79.2%, and that for TAE was 75.0%. Findings revealed (1) similar ophthalmoplegia complication rates (<em>p</em> = 0.744); (2) more frequent and permanent CN5 or CN7 neuropathy with liquid embolic agent use (<em>p</em> = 0.031 and 0.028, respectively); and (3) a higher risk of infarction or ICH (<em>p</em> = 0.002 and 0.028, respectively) in response to aggressive TAE.</p></div><div><h3>Conclusion</h3><p>Transvenous cavernous sinus coiling resulted in a similar occlusion rate and lower complication risk than transarterial Onyx/n-butyl cyanoacrylate (NBCA). We can access via an occluded inferior petrosal sinus (even contralateral), and direct transorbital puncture was a safe alternative. TAE with Onyx/NBCA was helpful in cases of oligo-feeders, but multidisciplinary treatment and multi-session TAE were usually needed for patients with multiple feeders and complex fistulas.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S231941702300094X/pdfft?md5=2c2370b7a56affdc671763cd91b96b25&pid=1-s2.0-S231941702300094X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10518907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for peri-intubation cardiac arrest: A systematic review and meta-analysis 插管周围心脏骤停的风险因素:系统回顾和荟萃分析
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-06-01 DOI: 10.1016/j.bj.2023.100656
Ting-Hao Yang , Shih-Chieh Shao , Yi-Chih Lee , Chien-Han Hsiao , Chieh-Ching Yen

Background

Peri-intubation cardiac arrest (PICA) is an uncommon yet serious complication of intubation. Although some associated risk factors have been identified, the results have been inconsistent. The aim of this study was to systematically review the relevant research and examine the associated risk factors of PICA through meta-analysis.

Methods

Studies examining the risk factors for PICA before 1 Nov. 2022 were identified through searches in MEDLINE (OvidSP) and EMBASE. The reported adjusted or unadjusted odds ratios (ORs) and risk ratios (RRs) were recorded. We calculated pooled ORs and created forest plots using a random-effects model to identify the statistically significant risk factors. We assessed the certainty of evidence for each risk factor.

Results

Eight studies were included in the meta-analysis. Pre-intubation hypotension, with a pooled OR of 4.96 (95% confidence interval [C.I.]: 3.75–6.57), pre-intubation hypoxemia, with a pooled OR of 4.43 (95% C.I.: 1.24–15.81), and two or more intubation attempts, with a pooled OR of 1.88 (95% C.I.: 1.09–3.23) were associated with a significantly higher risk of PICA. The pooled incidence of PICA was 2.1% (95% C.I.: 1.5%–3.0%).

Conclusions

Pre-intubation hypotension, hypoxemia, and more intubation attempts are significant risk factors for PICA. The findings could help physicians identify patients at risk under the acute setting.

背景插管前心脏骤停(PICA)是插管过程中一种不常见但却很严重的并发症。虽然已经发现了一些相关的风险因素,但结果并不一致。方法通过在 MEDLINE (OvidSP) 和 EMBASE 中检索,确定了 2022 年 11 月 1 日之前研究 PICA 危险因素的研究。记录报告的调整或未调整的几率比(ORs)和风险比(RRs)。我们计算了汇总的 ORs,并使用随机效应模型绘制了森林图,以确定具有统计学意义的风险因素。我们对每个风险因素的证据确定性进行了评估。插管前低血压的汇总 OR 值为 4.96(95% 置信区间 [C.I.]:3.75-6.57),插管前低氧血症的汇总 OR 值为 4.43(95% 置信区间:1.24-15.81),两次或两次以上插管尝试的汇总 OR 值为 1.88(95% 置信区间:1.09-3.23),这些因素与 PICA 风险显著增高有关。结论 插管前低血压、低氧血症和多次插管尝试是 PICA 的重要风险因素。这些发现有助于医生识别急性期的高危患者。
{"title":"Risk factors for peri-intubation cardiac arrest: A systematic review and meta-analysis","authors":"Ting-Hao Yang ,&nbsp;Shih-Chieh Shao ,&nbsp;Yi-Chih Lee ,&nbsp;Chien-Han Hsiao ,&nbsp;Chieh-Ching Yen","doi":"10.1016/j.bj.2023.100656","DOIUrl":"10.1016/j.bj.2023.100656","url":null,"abstract":"<div><h3>Background</h3><p>Peri-intubation cardiac arrest (PICA) is an uncommon yet serious complication of intubation. Although some associated risk factors have been identified, the results have been inconsistent. The aim of this study was to systematically review the relevant research and examine the associated risk factors of PICA through meta-analysis.</p></div><div><h3>Methods</h3><p>Studies examining the risk factors for PICA before 1 Nov. 2022 were identified through searches in MEDLINE (OvidSP) and EMBASE. The reported adjusted or unadjusted odds ratios (ORs) and risk ratios (RRs) were recorded. We calculated pooled ORs and created forest plots using a random-effects model to identify the statistically significant risk factors. We assessed the certainty of evidence for each risk factor.</p></div><div><h3>Results</h3><p>Eight studies were included in the meta-analysis. Pre-intubation hypotension, with a pooled OR of 4.96 (95% confidence interval [C.I.]: 3.75–6.57), pre-intubation hypoxemia, with a pooled OR of 4.43 (95% C.I.: 1.24–15.81), and two or more intubation attempts, with a pooled OR of 1.88 (95% C.I.: 1.09–3.23) were associated with a significantly higher risk of PICA. The pooled incidence of PICA was 2.1% (95% C.I.: 1.5%–3.0%).</p></div><div><h3>Conclusions</h3><p>Pre-intubation hypotension, hypoxemia, and more intubation attempts are significant risk factors for PICA. The findings could help physicians identify patients at risk under the acute setting.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":null,"pages":null},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023000938/pdfft?md5=cfa3fb8a3cf723e56b2f7c3f6430764e&pid=1-s2.0-S2319417023000938-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10145499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1